HK1012572A1 - Pyridylbishopsphonates for use as a therapeutical agent - Google Patents

Pyridylbishopsphonates for use as a therapeutical agent

Info

Publication number
HK1012572A1
HK1012572A1 HK98113970A HK98113970A HK1012572A1 HK 1012572 A1 HK1012572 A1 HK 1012572A1 HK 98113970 A HK98113970 A HK 98113970A HK 98113970 A HK98113970 A HK 98113970A HK 1012572 A1 HK1012572 A1 HK 1012572A1
Authority
HK
Hong Kong
Prior art keywords
pyridylbishopsphonates
therapeutical agent
bone diseases
pyridinylaminomethylidene
bisophosphonic
Prior art date
Application number
HK98113970A
Other languages
English (en)
Inventor
Marjaana Heikkila-Hoikka
Hannu Nikander
Ritva Hannuniemi
Leena Lauren
Terttu Kleimola
Sirpa Liukko-Sipi
Kalervo Vaananen
Raija Sellman
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of HK1012572A1 publication Critical patent/HK1012572A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
HK98113970A 1994-06-09 1998-12-17 Pyridylbishopsphonates for use as a therapeutical agent HK1012572A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402001A SE9402001D0 (sv) 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent
PCT/FI1995/000315 WO1995033466A1 (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent

Publications (1)

Publication Number Publication Date
HK1012572A1 true HK1012572A1 (en) 1999-08-06

Family

ID=20394303

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113970A HK1012572A1 (en) 1994-06-09 1998-12-17 Pyridylbishopsphonates for use as a therapeutical agent

Country Status (27)

Country Link
US (2) US5866556A (ko)
EP (1) EP0762883B1 (ko)
JP (1) JP3883137B2 (ko)
KR (1) KR100363692B1 (ko)
CN (1) CN1077792C (ko)
AT (1) ATE208622T1 (ko)
AU (1) AU691616B2 (ko)
BG (1) BG63104B1 (ko)
BR (1) BR9508185A (ko)
CZ (1) CZ291477B6 (ko)
DE (1) DE69523914T2 (ko)
DK (1) DK0762883T3 (ko)
EE (1) EE03475B1 (ko)
ES (1) ES2162919T3 (ko)
HK (1) HK1012572A1 (ko)
HU (1) HU228618B1 (ko)
IS (1) IS1801B (ko)
NO (1) NO311069B1 (ko)
NZ (1) NZ287094A (ko)
PL (1) PL180705B1 (ko)
PT (1) PT762883E (ko)
RO (1) RO119433B1 (ko)
RU (1) RU2154482C2 (ko)
SE (1) SE9402001D0 (ko)
SK (1) SK282650B6 (ko)
UA (1) UA43918C2 (ko)
WO (1) WO1995033466A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL351674A1 (en) * 1999-05-21 2003-05-19 Novartis Ag Use of bisphosphonic acids for treating angiogenesis
US20020103161A1 (en) 1999-12-17 2002-08-01 Manfred Weigele Novel heterocycles
IL150062A0 (en) 1999-12-17 2002-12-01 Ariad Pharma Inc Proton pump inhibitors
IL150059A0 (en) * 1999-12-17 2002-12-01 Ariad Pharma Inc Novel heterocycles
US20040014726A1 (en) * 2000-10-27 2004-01-22 Thua Osterman Method for the preparation of a pharmaceutical composition, and its use
EP1482897A2 (en) * 2002-02-19 2004-12-08 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
TW200413381A (en) * 2002-11-04 2004-08-01 Hoffmann La Roche Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
US20050010305A1 (en) * 2003-01-28 2005-01-13 Lee Francis Y. Novel bone graft composite
US20050065171A1 (en) * 2003-06-25 2005-03-24 Shakespeare William C. Substituted purine derivatives
JP2005060303A (ja) * 2003-08-12 2005-03-10 Sutaagen:Kk 不動性骨粗鬆の治療または予防剤
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447256A (en) * 1891-02-24 Apparatus for flashing and exhausting incandescent electric lamps
US4447256A (en) * 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
HU199151B (en) * 1987-03-10 1990-01-29 Yamanouchi Pharma Co Ltd Process for producing bis-phosphonic acid derivatives
EP0282309A3 (en) * 1987-03-11 1990-03-14 Yamanouchi Pharmaceutical Co. Ltd. Azole-aminomethylene bisphosphonic acid derivatives

Also Published As

Publication number Publication date
US5866556A (en) 1999-02-02
CN1077792C (zh) 2002-01-16
JPH10500977A (ja) 1998-01-27
NO965228D0 (no) 1996-12-06
DE69523914D1 (en) 2001-12-20
NZ287094A (en) 1998-04-27
BR9508185A (pt) 1997-08-12
KR100363692B1 (ko) 2003-02-07
WO1995033466A1 (en) 1995-12-14
US6083938A (en) 2000-07-04
EE9600191A (et) 1997-06-16
ATE208622T1 (de) 2001-11-15
PL317612A1 (en) 1997-04-14
JP3883137B2 (ja) 2007-02-21
DK0762883T3 (da) 2002-03-11
NO965228L (no) 1996-12-06
AU691616B2 (en) 1998-05-21
EP0762883B1 (en) 2001-11-14
PL180705B1 (pl) 2001-03-30
EP0762883A1 (en) 1997-03-19
IS4392A (is) 1996-12-02
DE69523914T2 (de) 2002-06-27
HU228618B1 (en) 2013-04-29
IS1801B (is) 2002-01-22
CZ291477B6 (cs) 2003-03-12
RO119433B1 (ro) 2004-11-30
NO311069B1 (no) 2001-10-08
AU2569895A (en) 1996-01-04
UA43918C2 (uk) 2002-01-15
BG63104B1 (bg) 2001-04-30
CN1149830A (zh) 1997-05-14
ES2162919T3 (es) 2002-01-16
CZ356196A3 (en) 1997-07-16
BG101116A (en) 1998-03-31
EE03475B1 (et) 2001-08-15
KR970703152A (ko) 1997-07-03
SK282650B6 (sk) 2002-10-08
HUT75525A (en) 1997-05-28
SE9402001D0 (sv) 1994-06-09
PT762883E (pt) 2002-05-31
SK157296A3 (en) 1997-06-04
RU2154482C2 (ru) 2000-08-20
HU9603375D0 (en) 1997-01-28

Similar Documents

Publication Publication Date Title
MX9707535A (es) Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario.
BG100910A (en) The use of bisphosphonates for the inhibition of osteal resorption after the implantation of orthopedic prosthesis
EP0662075A4 (en) PROSTAGLANDIN ANALOGUE FOR TREATING OSTEOPOROSIS.
AU3040995A (en) Treatment of autoimmune diseases by oral administration of autoantigens
SE8704248D0 (sv) Medical use
PL309693A1 (en) Combined osteoporosis inhibiting treatment
HK1012572A1 (en) Pyridylbishopsphonates for use as a therapeutical agent
EP0786995A4 (ko)
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
PL350917A1 (en) C16 unsaturated fp-selective prostaglandins analogs
HK1029937A1 (en) Use of phanquinone for the treatment of alzheimer s disease.
GR3035389T3 (en) Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
SE8903529D0 (sv) Medical use
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
MX9606180A (es) Piridilbisfosfonatos para utilizarse como un agente terapeutico.
CA2192456A1 (en) Pyridylbisphosphonates for use as a therapeutical agent
HUT50034A (en) Process for producing pharmaceutical compositions against retroviral diseases, containing butyl hydroxyanisole
AU1348302A (en) A method of determining the initial dose of vitamin d compounds
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
IT1255218B (it) Gamma-derivati del gamma-butirrolattone, processi per la loro preparazione e composizioni terapeutiche che li contengono per il trattamento di patologie con sintomatologia convulsiva ed ansiosa
NO934690L (no) Anvendelse av atipamezole for behandling av menns impotens
IL145297A0 (en) Use of an agent for the manufacture of a medicament for the treatment of bone diseases
UA10093A (uk) Спосіб лікування захворювань товстої кишки
IT1269823B (it) Difosfonati e loro impiego farmacologico nel trattamento dell'osteoporosi

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20150601